NCCAM
This article was originally published in The Tan Sheet
Executive Summary
Botanical-drug interaction grants to receive $4.3 mil. in FY 2001 funding, the NIH center announces in a request for applications released Aug. 7. NCCAM plans to support 10 Exploratory/Developmental Research (R21) grants and five investigator-initiated (R01) awards. Mechanistic, case control and Phase I and II trials will be considered. Letters of intent are due Nov. 10 and applications must be submitted by Jan. 12, 2001; the anticipated award date is August 2001. NCCAM's advisory council reviewed and endorsed the program concept in May (1"The Tan Sheet" May 15, p. 15)
Botanical-drug interaction grants to receive $4.3 mil. in FY 2001 funding, the NIH center announces in a request for applications released Aug. 7. NCCAM plans to support 10 Exploratory/Developmental Research (R21) grants and five investigator-initiated (R01) awards. Mechanistic, case control and Phase I and II trials will be considered. Letters of intent are due Nov. 10 and applications must be submitted by Jan. 12, 2001; the anticipated award date is August 2001. NCCAM's advisory council reviewed and endorsed the program concept in May (1 (Also see "Botanical/Drug Interactions To Be Studied By NCCAM" - Pink Sheet, 15 May, 2000.)). |